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Stroke has become the number three killer disease in Malaysia following heart disease 
and cancer; with 110 of people dying from it every day.  The effects of stroke often 
lead to life-changing, permanent impairment to the patients such as paralysis, speech 
and logic sequencing.  Hence, recent studies are looking into stroke treatments with 
minimal after surgical effect to patients.  One of the alternatives is using mechanical 
thrombectomy devices.  In this project, the simulation for ‘GP’ 2 device which 
functions to extract the blood clot in the artery without damaging the arterial wall and 
causing downstream embolism is presented.  The simulation will be carried out using 
computational fluid dynamics; applying the Volume of Fluid (VOF) model.   
 
In grid size selection, it is clear that finer grids results in higher accuracy calculations 
i.e. better results.  However, this is achieved at the cost of prolonged computational 
time.  From grid sensitivity study in identifying the optimum grid size that is fine 
enough to generate accurate calculations but large enough to avoid extra 
computational time; the grid size of 0.2mm is used.   
 
The design for ‘GP’ 2 Device has to be characterised to identify which of the two 
proposed designs is efficient for the suction of blood clot for 100% occlusion in the 
Middle Cerebral Artery.  Design for ‘GP’ 2 Model 1 device is better at clot extraction 
than the Model 2 device because increase in surface area for suction favours same-
suction principle rather than vortex creation to break the clot.  Theoretically, higher 
pressure results in faster clot extraction.  However, the value of pressure applied shall 
be observed closely so that no arterial damage is done and it can be applied for 
clinical tests.  For both models, it can be shown that higher pressure extracts blood 
clot at lower time whereby the fastest clot extraction occurs at time 0.00498s for 
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1.1 Project Background 
 
Millions of people suffer from stroke annually.  Stroke, or cerebrovascular accident 
(CVA), occurs when blood supply to part of the brain is disturbed, causing brain cells 
to die; because brain cells need constant supply of oxygen and glucose to 
function(Wedro, 2009).  Blood flow can be compromised by a variety of mechanisms 
such as blockage of the artery or rupture of the artery (Wedro, 2009).  Arterial 
blockage can be caused by several factors such as narrowing of the small arteries 
inside the brain, hardening of the major arteries supplying blood to the brain and also 
formation of blood clots from the heart to the brain, called embolism (Wedro, 2009).  
Arterial rupture on the other hand, is bleeding in the brain due to high blood pressure 
(Wedro, 2009).  There are two main types of stroke, ischemic 
stroke and haemorrhagic stroke.  Ischemic stroke accounts for about 75% of all 
strokes and occurs when a blood clot (thrombus) forms and blocks blood flow to part 
of the brain (Crosta, 2009).  This wandering clot may be carried through the 
bloodstream to the brain where it can cause ischemic stroke (Crosta, 2009).  A 
haemorrhagic stroke occurs when a blood vessel on the brain's surface ruptures and 
fills the space between the brain and skull with blood or when a defective artery in the 
brain bursts and fills the surrounding tissue with blood (Crosta, 2009).   
 
The blockage of an artery in the brain by a clot (thrombosis) is the most common 
cause of a stroke (Wedro, 2009).  The part of the brain that is supplied by the clotted 
blood vessel is then deprived of blood and oxygen, and as a result the cells of that part 
of the brain die and the body part that it controls stop working (Wedro, 2009).  
Medical institutions nowadays are finding the best possible method to remove the 
blockage (blood clot) with minimal effect to the brain to reduce the after-surgical 
effect to the patients.  Ideally, removing the blood clot and re-establishing normal 
flow in the affected artery shall cure patients with stroke with minimal after surgical 
effect.  Such method is called thrombosis.  In understanding thrombosis, according to 
Bernsdorf (2005), a comprehensive understanding of Virchow’s triad must be 
accomplished.  Virchow’s triad discusses the factors thought to cause thrombosis.  In 
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the first triad, alterations in normal blood flow.  In the second triad, phenomena 
associated with irritation of the blood vessel and its vicinity, and the third triad; 
alterations in the constituents of blood. 
 
Generally, the treatment for stroke depends on what causes stroke for the patient; 
either by blood clot (ischemic) or bleeding in the brain (haemorrhagic).  However, we 
will refine the research area covering only stroke caused by blood clot which is the 
common case for stroke.  For patients diagnosed soon enough after the show for 
symptoms, they will be given a clot-dissolving medicine called tissue plasminogen 
activator (t-PA).  t-PA acts to dissolve the blood clot and re-establishing normal blood 
flow by biochemical reaction.  However, the usage of t-PA has their limitations.  Due 
to the risk of haemorrhage (abnormal bleeding)   it is contraindicated to patients who 
have undergone recent surgery (Romero, Higuera, Martinez, Pearce, & Perkinson, 
2010).  In addition, it has to be given at a relatively early time after stroke has 
occurred and be used up to 4 to 5 hours post-stroke(Romero, Higuera, Martinez, 
Pearce, & Perkinson, 2010).  Hence, with these available limitations, mechanical 
thrombectomy devices are recently developed as alternative means for clot removal. 
 
In recent years, Mechanical Thrombectomy Devices (MTD) has become widely used 
as an alternative to remove blood clots.  The Gwen Pearce Thrombectomy Aspiration 
Device (GP TAD) is designed to mechanically remove the blood clot from the artery 
and re-establish normal blood circulation to the brain.  The extraction of the clot by 
the device is done by means of vacuum suction provided by a pump (Pearce G. , 
Perkinson, Romero, Martinez, & Felez, 2011).  The vacuum suction generates a 
vortex created by a mathematical design of its internal surface to facilitate suction of 
the clot.  Such characteristic also gives rise to low forces on the periphery of the 
device; therefore, less risk of arterial collapse (Pearce G. , et al., 2009).  Previously, a 
research was carried out to prove the theoretical hypothesis associated with the ‘GP’ 
Device.   In this project however, two new designs for ‘GP’ device mark 2 are studied 
using computational fluid dynamics.   
 
The need to study new MTD devices means that a computer pre-modelling may be 
helpful in the optimization and fine-tuning of the medical devices prior to clinical 
trials (Pearce G. , Perkinson, Romero, Martinez, & Felez, 2011).  One of the subjects 
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of interest in relation to finding cure for stroke is to study the fluid flow for the blood 
clot and its behaviour when a mechanical device is used to remove it.  Studies 
comparing the experimental data and simulation data are carried out to prove the 
theories associated with the designed devices.  Simulating the dynamics of fluid flow 
can be done by Computational Fluid Dynamics (CFD).  Users are able to generate the 
domain geometry in which the desired computations are iterated.  This is a virtual way 
of carrying out the experiments by setting up the necessary boundary conditions and 
let the software calculate the outcome fluid dynamics parameters.   
 
Computational fluid dynamics (CFD) is branch of fluid mechanics which uses 
numerical methods to solve and analyse problems related to fluid flows.  CFD is a 
powerful, reliable and efficient tool; carried out using computers to perform required 
calculations to simulate the interaction of fluids with surfaces predefined by boundary 
conditions.  One of the advantages of using CFD is it provides a platform for low cost 
but relatively accurate research because it allows the simulation for real time 
conditions without having to build the equipment to carry out the laboratory 
experiments.  Besides that, using CFD is safe because the research does not involve 
experiments on human beings.  Therefore, it allows for preliminary detection for 
possibilities of risks when the ‘GP’ 2 device is applied to patients later on.  In this 
project, ANSYS FLUENT (FLUENT) software will be used to carry out the 
simulations; and ANSYS DesignModeler (DesignModeler) will be used to generate 





1.2 Problem Statement 
 
Mechanical thrombectomy devices are one of the methods to remove blood clot in the 
artery.  However, most mechanical devices have the drawback of using moveable 
parts, or involve contact with luminal wall (Pearce, Patrick, & Perkinson, A New 
Device for the Treatment of Thromboembolic Strokes, 2007).  The recently invented 
and patented ‘GP’ device avoids many potential problems associated with the usage 
of mechanical devices in removing blood clot such that it has no moving parts and 
does not need to touch the blood clot to facilitate clot removal(Pearce G. , et al., 
2009).  The application of suction through a micro-catheter allows removal of blood 
clot and any subsequent debris without the necessity for direct contact with the clot 
surface (Pearce, Patrick, & Perkinson, A New Device for the Treatment of 
Thromboembolic Strokes, 2007).  The ‘GP’ device has a tube of helical spiral design 
embedded at the last 20mm end of the micro-catheter.  The schematic view of the 
‘GP’ clot removal device is as shown below: 
 
Figure 1: 2D schematic view of GP device (Pearce, Patrick, & Perkinson, A New 
Device for the Treatment of Thromboembolic Strokes, 2007) 
 
Moreover, a newer design ‘GP’ 2 device has 9 helical spiral or cylindrical tube around 
the periphery of the device.  With the increase in number of tubes, it is assumed to be 
more efficient such that blood clot suction can be done with lesser time at the same 
applied suction force.  Hence, ‘GP’ 2 device is theoretically an improved design of the 
‘GP’ device allowing more efficient clot removal.  The mode of operation for ‘GP’ 2 
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device is similar to ‘GP’ device.  Below is the 2D sketch showing the difference in the 










Figure 2: 2D sketch for the geometry of ‘GP’ device (left) and ‘GP’ 2 device (right) 
 
Implementing these devices on human beings is the ultimate goal.  It is invented to be 
used to cure for stroke in humans.  However, testing for the feasibility to use this 
device to cure for stroke in human beings can be very risky.  Since the device is small 
and the operating conditions severe, instrumentation for making necessary flow 
measurements is extremely difficult to design; therefore it became necessary to look 
at the flow by computational means (Kiris & Kwak, 2007).  Hence, an alternative 
method to experiment and to testify if these devices can be used to cure stroke for 
human beings is by using CFD simulation.  This is because, CFD allows for real time 










1.3 Objectives and Scope of Study 
 
The objective of this study is to carry out 3D FLUENT simulations to compare the 
two proposed designs of ‘GP’ 2 device for the treatment of thromboembolic strokes in 
Middle Cerebral Artery (MCA); an artery where blood clot in stroke patients most 
commonly occur.  Model specifications are as tabulated below: 
Model type / 
Description 
Model 1 Model 2 










Table 1: Geometry specification for the two proposed designs for ‘GP’ 2 device 
 
The scope of this research is outlined as follows: 
 Create and mesh the geometry domains using DesignModeler 
 Carry out grid sensitivity study to identify the most accurate but coarse grid to 
minimize computational time without jeopardizing the accuracy of the results. 
 Carry out the simulation using FLUEN for a range of pressures  
 Compare the two designs to identify the best geometry for clot removal. 
 
This research will useful to Dr. Gillian Pearce of Kiel University, United Kingdom and 
her team of collaborators, for preliminary results to compare between the two models of 
‘GP’ 2 device.  Deeper and more insightful research on this device to determine its 











This section emphasizes on the previous studies carried out which are related to the 
subject matter and its relation to the development of this study.  In the first section, 
current available methods to remove blood clot are discussed.  In the second section, 
theories and studies related to the modelling of blood clot are discussed.  Finally, in 
the last section, the theories related to the computational methods used in the software 
FLUENT are discussed.   
 
2.1 Methods to Remove Blood Clot in Artery 
 
Treatment efforts to clear blood clot causing stroke has been made directly by 
surgery, with clot-dissolving drugs (thrombolysis), or by inserting a mechanical 
thrombectomy device (MTD) (Pearce, Perkinson & Patrick, 2007).  The drawback of 
thrombolysis is the short therapeutic time window of 3 hours after stroke onset and 
the contraindication effects it has on some patients, making the range of patients 
suitable to receive cure treatment smaller.   
 
A study carried out by Tennuci et al (2011), a comparison for the effectiveness of 
three methods of recanalization in a model of the Middle Cerebral Artery; comparing 
i) thrombus aspiration via a 4F catheter, ii) thrombus aspiration via the ‘GP’ thrombo-
aspiration device, and iii) mechanical thrombectomy using the solitaire thrombectomy 
device shows that thrombus aspiration is faster with the usage of mechanical 
thrombectomy.  The three methods of recanalization of an occluded vessel were tested 
in a pulsatile model of the cerebral circulation.  The pulsatile environment is created 
using a peristaltic pump creating the pulse in a Hartmann’s solution placed in a beaker 
in a 37° C water bath (Tennuci, et al., 2011).  A silicone model with 3mm internal 
diameter is used as Middle Cerebral Artery (MCA).  The main finding of this study 
shows that all three devices successfully removed majority of clots in the MCA.  
Recanalization rate is 15% higher with the ‘GP’ TAD than with the 4F catheter; and a 
further 8% higher with the Solitaire than the ‘GP’TAD (Tennuci, et al., 2011).  In this 
study, the GPTAD appeared to grasp the clot better than the 4F catheter, with more 
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successful first-attempt removals, and this may have caused less fragmentation 
(Tennuci, et al., 2011).  However, once the clot was grasped, clot removal was 
smooth. Both devices appeared to stretch the clot on removal (Tennuci, et al., 2011).  
The GPTAD creates a vortex with suction and does not touch the clot during removal 
thus reducing the risk of fragmentation compared to the 4F catheter (Tennuci, et al., 
2011).  The Solitaire device uses an open-slit, closed cell design which interacts with 
the thrombus, giving an optimal radial force, increasing the chance of clot trapping 
(Tennuci, et al., 2011).  In this study, it ensnared clots up to 45mm of length within 
the struts of the device (Tennuci, et al., 2011).  From this study, it shows that 
extraction of blood clot via mechanical thrombectomy (‘GP’ TAD and Solitaire) is 
more efficient.   
 
One of the established mechanical thrombectomy devices is the Mechanical Embolus 
Removal in Cerebral Ischemia (MERCI).  Gobin et al (2004) reports the result of 
MERCI 1 study, a phase 1 trial to evaluate the safety and efficacy of mechanical 
embolectomy in the cerebral vasculature to 28 patients in 7 US centres.  Using 
standard cerebral catheterization techniques, the micro-catheter was guided into the 
occluded vessel and pass beyond the thrombus (Gobin, et al., 2004).  A selective 
angiogram was performed distal to the thrombus to evaluate the size and tortuosity of 
the distal arteries, where the Merci Retriever was to be deployed (Gobin, et al., 2004).  
The Merci Retriever was then advanced through the micro-catheter and 2 to 3 helical 
loops were deployed beyond the thrombus (Gobin, et al., 2004).  The Merci Retriever 
was then retracted at the contact of the thrombus, and proximal loops were then 
deployed within the thrombus (Gobin, et al., 2004).  The balloon guide catheter 
(BGC) was inflated to control intracranial blood flow during removal of the thrombus 
and 5 clockwise rotations were applied to the Merci Retriever to further ensnare the 
thrombus(Gobin, et al., 2004).  The Merci Retriever, with the ensnared thrombus, and 
the microcatheter, were withdrawn together into the BGC lumen (Gobin, et al., 2004).  
Continuous aspiration was applied to the BGC to ensure complete evacuation of the 
thrombus (Gobin, et al., 2004).  The balloon of the BGC was deflated to re-establish 
flow; and upon confirmation of complete evacuation of thrombus, a repeat angiogram 









Figure 3: Steps for thrombus removal using MERCI (Gobin, et al., 2004) 
 
The result of this study shows 43% of successful recanalization in the patients and an 
additional 21% of the patients had successful recanalization with the aid of a 
thrombolytic agent (Gobin, et al., 2004).  However, most mechanical devices have the 
drawback of using moveable parts, or involve contact with the luminal wall; which 
could cause downstream embolization of clot pieces or even broken catheter tips 
(Pearce, Perkinson& Patrick, 2007).  In the case of MERCI, there was one 
complication when the tip of the Merci Retriever detached from the device (Gobin, et 
al., 2004).  Another Merci Retriever was used to ensnare the detached tip and 
successfully remove it from the vasculature; and had no clinical consequence (Gobin, 
et al., 2004).  The recently invented and patented ‘GP’ MTD avoids many potential 
problems associated with the usage of mechanical devices in removing blood clot 
such that it has no moving parts and does not need to touch the blood clot to facilitate 






2.2 Blood Clot Simulation  
 
Blood clotting usually occurs when the blood vessel is damaged.  This causes platelets 
to adhere to the broken wall and release chemicals which attract more platelets.  Upon 
formation of a platelet plug, the external bleeding is stopped.  Then, clotting factors 
cause strands of blood-borne materials (fibrin) to stick together and seal the inner 
wound (Wedro, 2011).    Bernsdorf (2005) in his study for the concurrent numerical 
simulation of the unsteady flow within an idealised stenosed artery and a simplified 
blood clotting process based on a residence time model claims that a comprehensive 
understanding of thrombosis requires full consideration of the three entities of 
Virchow’s’ triad; blood chemistry, vessel wall properties and fluid mechanics.  This 
simulation utilises the lattice Boltzmann method; which is based on the numerical 
simulation of time, space and velocity-discrete Boltzmann-type equation.  The 
propagation and interaction of the particles of an ‘artificial computer fluid’ is 
calculated in terms of the time evolution of a density distribution function, 
representing and ensemble average of the particle distribution (Bernsdorf, 2005).  In 
this study, the residence time model refers to the aging of the blood clot.  Assuming 
that clotting occurs after a certain elapsed period since the ‘activation’ of blood; the 
residence time of the activated fluid is the most important variable for the clotting 
process because it indicates the likelihood of clot formation (Bernsdorf, 2005).  A 
passive scalar is used as a tracer to estimate the residence time of activated fluid in 
this model (Bernsdorf, 2005).  This tracer is transported by advection-diffusion and a 
small, constant quantity is injected at every lattice node each time step (Bernsdorf, 
2005).  The local concentration of the tracer is therefore proportional to the average 
‘age’ of the fluid (blood) which can be used as a threshold parameter within the 
clotting model(Bernsdorf, 2005).  The 2D simulation results obtained from 
Bernsdorf’s study (2005) shows good agreement for the simulation of clot formation, 
comparable to results of milk clotting experiments using comparable flows.  However, 
for better accuracy and representation of blood clot formation, a 3D model should be 
simulated.      
 
An important parameter to study in blood clot simulation is the adhesion forces 
between blood clot and the artery wall.  In a study carried out by G. Romero, I. 
Higuera, M.L. Martinez, G. Pearce, and N.D. Perkinson (2010), simulation using 
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Bond Graph technique is carried out to analyse the adhesion forces between clot and 
artery wall for the GP device applied to the Middle Cerebral Artery.  The main 
objective of this simulation is to analyse the minimum pressure required to perform 
the blood clot extraction with varying adhesion forces between clot and the artery 
wall, and to check that both the pressure and time required to complete the clot 
extraction are reasonable for use in clinical situations, and are consistent with any 
experimentally obtained data.  To generate a correct model, assimilation of the 
catheter, ‘GP’ device and artery as pipes of different materials are done and inertance 
due to mass of fluid, the compressibility that the blood and artery are subjected, and 
finally the resistances that appear when fluid and blood clot flow into the 
pipe(Romero, Higuera, Martinez, Pearce, & Perkinson, 2010).  The phenomena 
preventing clot movement is the difference in diameter between the clot and the artery 
where it is located.  In order to decide when to begin the movement of the obstructive 
element, firstly a spring needs to be inserted into the model to measure the force 
supported by the beginning of the clot and its deformation (Romero, Higuera, 
Martinez, Pearce, & Perkinson, 2010).  To obtain the value of this spring the 
phenomenon of surface tension must be taken into account, since it is this that joins 
the clot to the artery. This surface tension  comes about from the attraction forces 
between molecules and is defined as force by unit length (Romero, Higuera, Martinez, 
Pearce, & Perkinson, 2010).   
                                                     (2.2.1)  
If we take the sphere in figure 3, the surface tension would act on the circumference 
of the contact between the clot and the artery (marked with a blue ellipse). 
 
Figure 4: Model for surface tension (Romero, Higuera, Martinez, Pearce, & 
Perkinson, 2010)  
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Bearing in mind the previous, if the value of the length of contact from the radius r of 
the artery is taken into account, the value for the surface tension can be obtained and, 
in turn, the value for the spring coefficient as: 
                                (2.2.2) 
The clot is between [3-5] cm long, which means it can be broken down into the union 
of several spheres, all with the same constant.  Since over the whole surface of the 
clot there are adhesion forces, to obtain a correct approximation it is necessary to 
consider the existence of a sphere for every 0.1 mm (Romero, Higuera, Martinez, 
Pearce, & Perkinson, 2010). This means that between 300 and 500 spheres located in 
parallel, with each sphere in contact at 2 diametrical opposite points with the artery 
wall, would need to be included in the model. On the other hand, since the clot 
behaves like a rigid body, the fact that all the spheres are located in parallel must be 
taken into account, so that until the resultant adhesion force is overcome in all of the 
spheres, the clot will not begin to move (Romero, Higuera, Martinez, Pearce, & 
Perkinson, 2010).  Therefore, since all the individual springs are equal, the equivalent 
spring for a 5 cm clot can be had from the form appearing in the following expression: 
                        (2.2.3) 
To know when the force will be reached in this equivalent spring and, therefore, when 
the clot movement will begin, it is essential to calculate the displacement of the spring 
when it is subjected to 0.01 N (i.e.) through a typical spring equation(Romero, 
Higuera, Martinez, Pearce, & Perkinson, 2010). Therefore, only when the spring 
undergoes this displacement should the clot be allowed to move; to the contrary it 
would be prevented. 
                 (2.2.4) 
Secondly, in Romero’s (2010) study the friction between the clot and the arterial wall 
creates another resistance factor.  The value of this parameter is variable, depending 
on whether the clot has begun its movement, (dynamic fraction) or is still motionless 
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(static friction).  This value is obtained starting from the Stokes equation and can be 
given a value of          N.s/m for static friction and an order of magnitude lower 
for dynamic friction (Romero, Higuera, Martinez, Pearce, & Perkinson, 2010).  So, 
when the displacement undergone by this spring is less than that calculated, static 
friction rules, but when greater, the friction will be dynamic.   
 
To ensure that the clot remains at rest while the force existing at its beginning is less 
than the adhesion force, a spring-damper system joined to a wall (zero flow source) 
must be used.  In this system, while the clot does not receive the force of minimum 
suction, it has zero speed (no movement by the clot), but when it begins to move, the 
spring-damper system is cancelled to allow extraction by the ‘GP’ device (Romero, 
Higuera, Martinez, Pearce, & Perkinson, 2010).    
 
Figure 5: Left figure shows the spring-damper system when force exerted is lower 
than the adhesion force; and the figure on the right shows when force exerted is equal 
or greater than the adhesion force (Romero, Higuera, Martinez, Pearce, & Perkinson, 
2010) 
 
Romero’s (2010) study concludes that lower adhesion force requires lesser pressure 
and time for the extraction of blood clot in Middle Cerebral Artery.  His study is one 
of the basis theory for the development of the blood clot extraction simulation by the 







A study carried out by KuShaari, A. Rahman and Pearce (2012) on blood clot 
behaviour upon extraction by ‘GP’ device by CFD Simulation states that blood does 
not exhibit a constant viscosity at all flow rates compared to water and is non-
Newtonian in the microcirculatory system (in small branches and capillaries).  The 
normal blood flow is laminar with secondary flows generated at curves or 
branches(KuShaari, A.Rahman, & Pearce, 2012).  The Reynolds number varies from 
1 in small arterioles to approximately 4000 in the largest artery (KuShaari, A.Rahman, 
& Pearce, 2012).  The heart creates pulsating conditions in all arteries, making the 
blood flow and pressure unsteady.  A grid sensitivity study was also conducted by 
assessing the effect of the grid size on pressure and laminar properties (KuShaari, 
A.Rahman, & Pearce, 2012).  In each case, the grid density was varied from coarse to 
fine by increasing the number of cells in the whole device generally, including the 
wall.  Grid independency is said to be achieved when any further increase in the 
number of cells did not adversely affect the simulation results; the optimum grid size 
avoided any unnecessary prolonged computational effort required for the simulations 
with large number of cells (KuShaari, A.Rahman, & Pearce, 2012).  Their study 
concludes that finer grid size results in higher accuracy result.  Besides that, it is 
found that the fastest time to remove the blood clot of 0.6-1g weight at 0.0035Pa.s 
viscosity is 0.006s, when 60kPa pressure is applied.  The findings of this study will 
also be the basis for the research works on ‘GP’ 2 device.    
 
A study carried out by Serza, Tratar & Blinc (2005) states that the rate of 
thrombolysis, i.e, the progression rate of lysing front dr/dt is proportional to the 
average mechanical power of the flowing blood to the surface of the flow channel.  
The power, P is equal to the force F of the flowing blood to the clot surface multiplied 
by the average blood velocity in the flow channel v.  The force F is also equal to the 
product of pressure drop ∆p across the flow channel multiplied by the cross-section 
area of the flow channel, S (Serza, Tratar, & Blinc, 2005).  The pressure drops for 
laminar and turbulent flow are governed by different set of equations.   
                                                         (2.2.5) 
Thus, the study carried out by Serza (2008) concludes that blood clot deformation is 
governed by both biochemical reactions of the thrombolytic agents and mechanical 




Figure 6: Viscous forces to dissolve blood clot when blood flow is laminar (Serza, 
Tratar, & Blinc, 2005) 
  
 
Figure 7: Kinematic forces to dissolve blood clot when blood flow is turbulent (Serza, 
Tratar, & Blinc, 2005) 
 
In a different study carried out by Pearce et al (2010), an in vitro testing was carried 
out for the new ‘GP’ aspiration thrombus device.  In the first experiment, relationship 
between clot weight and pressure required for clot extraction is carried out.  The clots 
used are in the range of 0.03g – 0.13g with needed pressure of the range 30 and 34 
kPa.  The results obtained shows linear relationship between size of clot and pressure 
applied; with larger clots requiring higher extraction pressures.  After the experiments, 
sections of the porcine arteries were taken for examination.  It showed no arterial 
damage for extraction pressure applied between 30kPa – 40kPa.  From this study, it 
shows that laboratory experimental results show positive outcome in using the ‘GP’ 










2.3 Theory on Computational Methods using FLUENT 
 
In a research carried out by C. Kiris and D. Kwak (2007), the applicability of the 
DeBakey heart assist device (a type of ventricular assist device, VAD) is studied 
using space technology and CFD for its usage in human implantation to increase 
blood circulation in heart-failure patients awaiting transplant.  Because blood is the 
operating fluid, the design of a VAD requires that it propel the blood gently, 
minimizing damage to the red blood cells (Kiris & Kwak, 2007).  In order to reduce 
red blood cell damage, the pumping device must be designed to avoid regions of high 
shear stress and separated flow in the pump (Kiris & Kwak, 2007).  In addition, the 
blood must be properly washed out of the pump since the formation of blood clots 
may appear within stagnation regions as a result of previously damaged blood cells.  
Since the device is small and the operating conditions severe, instrumentation for 
making necessary flow measurements is extremely difficult to design; therefore it 
became necessary to look at the flow by computational means (Kiris & Kwak, 2007).  
This study shows the reliability of CFD in the optimisation of devices needing high 
accuracy to be implemented in humans.   
 
Simulation for the suction of the blood clot in the artery using CFD utilises the 
Navier-Stokes equation.  This set of equation describes fluid substances’ motion.  It 
originates by applying Newton’s Second Law of Motion (F=ma) into fluid motion 
and assuming that the fluid stress is a sum of diffusing viscous term and a pressure 
term.  Romero et al (2011) stated that blood is deemed to be an incompressible fluid.  
Hence, Navier-Stokes equation for incompressible flow, assuming constant viscosity 
is used throughout the simulation and takes the following form:  
        (2.3.1) 
 
Where v = flow velocity,   = density of blood plasma, p = pressure,   = viscosity.  
The term f, or other body forces represents gravity or centrifugal force.  The 
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divergence of stress terms, or shear stress is the useful quantity when fluids are 
assumed incompressible, Newtonian and homogeneous.   
 
In running this simulation, CFD multiphase flow is observed.  The concept of 
multiphase flows in CFD is not limited to only physical mixture of phases, but refers 
to an identifiable class of material which has a particular inertial response to and 
interaction with the flow and the potential field in which it is immersed.  In this case, 
the blood and blood clot are 2 different phases involved.  As mentioned earlier, the 
main objective of this study is to identify the interaction and behaviour of the blood 
clot upon suction by the ‘GP’ device.  Hence, the multiphase model to be applied in 
this situation is the Volume of Fluid (VOF) Model.  The VOF model isa surface-
tracking technique applied to a fixed Eulerian mesh (Fluent 6.3 User Guide , 2006).  It 
is designed for two ormore immiscible fluids where the position of the interface 
between the fluids is of interest (Fluent 6.3 User Guide , 2006).  In the VOF model, a 
single set of momentum equations is shared by the fluids, and the volume fraction of 
each of the fluids in each computational cell is tracked throughout the domain (Fluent 
6.3 User Guide , 2006). Applications of the VOF model include stratified flows, free-
surface flows, falling, sloshing, the motion of large bubbles in a liquid, the motion of 
liquid after a dam break, the prediction of jet breakup (surface tension), and the steady 
or transient tracking of any liquid-gas interface (Fluent 6.3 User Guide , 2006). 
 
The VOF formulation relies on the fact that two or more fluids (or phases) are not 
interpenetrating.  For each additional phase added to the model, a variable is 
introduced; the volume fraction of the phase in the computational cell (Fluent 6.3 
User Guide , 2006). In each control volume, the volume fractions of all phases sum to 
unity. The fields for all variables and properties are shared by the phases and represent 
volume-averaged values, as long as the volume fraction of each of the phases is 
known at each location (Fluent 6.3 User Guide , 2006). Thus the variables and 
properties in any given cell are either purely representative of one of the phases, or 
representative of a mixture of the phases, depending upon the volume fraction 
values(Fluent 6.3 User Guide , 2006).In other words, if the q
th 
fluid's volume fraction 
in the cell is denoted as  ; then the following three conditions are possible: 





     : The cell is full for the q
th
fluid 
         : The cell contains the interface between the q
th
fluid and one or 
more other fluids 
Based on the local value for   , the corresponding properties and variables will be 
assigned to each computational cell.  The tracking of the interfaces between the 
phases is accomplished by the solution of a continuity equation for the volume 
fraction of one or more of the phases (Fluent 6.3 User Guide , 2006).  For the q
th
 
phase, this equation has the following form: 
(2.3.2) 
Where mqp is the mass transfer from phase q to phase p and mpq is the mass transfer 
from phase p to phase q; by default, the source term on the right-hand side of 
Equation 3.1.1.1, Sq, is zero, but a constant or user-defined mass source can be 
specified for each phase(Fluent 6.3 User Guide , 2006).  The volume of fraction 
equation will not be solved for the primary phase, because the primary phase will be 
computed with the following constraint: 
∑   
 
            (2.3.3) 
 
Generally, simulation using CFD utilises the concept of interpolating the values for 
every desired properties and variables from one control volume (computational cell) 
to another.  In using the VOF model, the constraint shall be the interpolation at the 
interface between phases; whereby it uses two schemes; the geometric reconstruction 
scheme and the donor-acceptor scheme.   
 
The geometric reconstruction scheme is the most accurate and applicable for general 
unstructured meshes.  This type of scheme utilises the piecewise linear approach 
whereby it assumes that the interface between the two phases has a linear slope within 
each cell and uses this linear shape for calculation of the advection of fluid through 




The donor-acceptor scheme identifies one cell as a donor of an amount of fluid from 
one phase and another (neighbour) cell as the acceptor of that same amount of fluid, 
and is used to prevent numerical diffusion at the interface(Fluent 6.3 User Guide , 
2006). The amount of fluid from one phase that can be convected across a cell 
boundary is limited by the minimum of two values: the filled volume in the donor cell 
or the free volume in the acceptor cell (Fluent 6.3 User Guide , 2006).  The orientation 
of the interface is also used in determining the face fluxes. The interface orientation is 
either horizontal or vertical, depending on the direction of the volume fraction 
gradient of the q
th
 phase within the cell, and that of the neighbour cell that shares the 
face in question(Fluent 6.3 User Guide , 2006).    
 
 
Figure 8: (a) Actual interpolation shape between phases; (b) interpolation by 
geometric reconstruction scheme; (c) interpolation by donor-acceptor scheme (Fluent 
6.3 User Guide , 2006) 
 
In simulating the behaviour of the blood clot upon extraction, the effects of surface 
tension and wall adhesion are important.  Surface tension is a result of attractive 
forces between the molecules in a fluid.  It is a force which acts to balance the radially 
inward intermolecular attractive forces with the radially outward pressure gradient 
force across the surface.  The surface tension can be written in terms of the pressure 
jump across the surface (Fluent 6.3 User Guide , 2006). The force at the surface can 
be expressed as a volume force using the divergence theorem (Fluent 6.3 User Guide , 
2006). It is this volume force that is the source term which is added to the momentum 
equation (Fluent 6.3 User Guide , 2006).  It has the following form: 
  (2.3.4) 
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where     is surface curvature, dependent on divergence of the unit normal,      
     and   is surface tension coefficient 
 
In the VOF model, wall adhesion calculation is assumed to be the contact angle 
between the fluid and the adjacent wall to adjust the calculated value for curvature (K) 
of the surface near the wall.  With the adjustments made from the calculation of 
curvature, the surface tension is also affected.  Adjustment to the curvature results 
from the direct proportionality of the surface normal (n) to the contact angle; given by 
the following equation: 
   (2.3.5) 






CHAPTER 3  
METHODOLOGY 
In this chapter, the methodology used achieve the desired results will be further 
explained.  Simulation algorithm will be shown and explained to help understand the 
work method used.   
 
3.1 Research Methodology & Project Activities 












Grid size study using ANSYS Fluent 
START ANSYS Workbench 
Generate geometry using ANSYS DesignModeler 




grid size  ? 
Case set up and run simulation 
Logical 
result? 








Geometry generated using ANSYS DesignModeler which is developed by ANSYS 
Inc. will be used as a pre-processor for this study.  DesignModeler is a state-of-the-art 
pre-processor suitable for engineering analysis.  It is equipped with an advanced 
geometry tools, which are highly flexible, systematic and allows for parametric study.  
Complex models can be generated directly using DesignModeler or can be imported 
from any major CAD/CAE system.  This geometry can then be read into the meshing 
tool embedded within ANSYS Workbench.  The meshing function in Workbench is 
highly-automated and equipped with predefined size function which allows faster, 
systematic and appropriate meshing.   
 
Then, the mesh file (.msh) is imported into the simulation software, ANSYS Fluent.  
Fluent allows for calculation for various types of physical models and fluid flows such 
as steady-state or transient flow, compressible and incompressible flows, laminar or 
turbulent flows, Newtonian or non-Newtonian flows, etc.  The case and data files 
(.cas& .dat) from Fluent are generated upon setting of boundary conditions prior to 
running the simulation.  Once the simulation has stopped (converged), post-
processing is done.  In post-processing, the related data are extracted and required 
calculations are carried out to obtain the desired parameter.  Once all calculations and 
data processing are complete, the results are documented for bookkeeping.  
 
3.1.1 Pre-processing 
In pre-processing, the geometry domains are generated, with dimensions as shown in 
the figures below: 
3.1.1.1 Geometry 
MODEL 1: Consist of 9 cylindrical tubes at 0.6mm diameter each. 
 






Figure 9: Side view of ‘GP’ 2 device, model 1 
 
MODEL 2: Consist of 9 helical spiral tubes of 0.6mm diameter each 
 
Figure 10: Isometric view (left) and front view (right) of ‘GP’ 2 device model 2 
 
Figure 11: Side view of ‘GP’ 2 device model 2 
 
3.1.1.2 Meshing 
Once the 3D geometries are generated, the next step is to adapt appropriate grid sizes 
i.e. meshing.  The mesh sizes are adapted such that it fits the range of appropriately 
coarse to appropriately fine meshes.  The size range of mesh is set to be between 





& Pearce (2012) whereby their study was based on the original 'GP' device.  A mesh 
is said to be appropriate if the mesh quality check is within the suggested quality 
range.  Mesh skewness (range from 0-1) is one aspect that determines mesh quality.  
From standard practices, the mesh skewness should be kept lower than 0.8 or 0.7 at 
best.  The diagram below shows an example of coarse mesh and fine mesh. 
 
Figure 12: Fine mesh (left) and coarse mesh (right) 
 
When meshing is complete, the geometry shall be labelled accordingly to allow 
boundary conditions to be defined in the simulation software later.  In a later stage, a 
grid sensitivity study will be carried out to determine which grid size is the best to 
carry out the simulation.  The choice of grid size shall be one that is large enough to 
cut computation time but small enough to provide accurate results. 
 
3.1.2 Simulation 
The next step is to run the simulation.  The solver type used is pressure-based, with 
transient time setup.  The multiphase, Volume of Fluid (VOF) model is selected in the 
model stage which allows the blood clot behaviour upon suction by the ‘GP’ device at 
various pressures to be visualized clearly.  The default settings for VOF in FLUENT 
are used; i.e. Explicit parameter scheme and 0.25 Courant number.  The number of 







Next, appropriate material properties, boundary conditions and operating conditions 
are specified.  The material properties of blood and blood clot are as shown in the 
table below: 
Parameter / Phase Blood Blood Clot 
Density (g/cm
3
) 1.06 1.08 
Viscosity (poise) 0.035 0.35 
Table 2: Material properties table (Soleimani, Pennati, & Dubini, 2011) (Nohirnyak, 
Suk, & Holland, 2006) 
 
The phases are set; with blood as primary phase and blood clot as secondary phase.  A 
phase interaction in the form of surface tension is set; with constant surface tension 
coefficient value of 0.1N/m (Soleimani, Pennati, & Dubini, 2011).   
 
The boundary conditions set are as below (KuShaari, A.Rahman, & Pearce, 2012): 
Boundary Condition Value 
Mixture Pressure Inlet 40, 50 & 60 kPa 
Mixture Pressure Outlet -40, -50 & -60 kPa 
Table 3: boundary conditions table  
 
The solution method is set to PISO; and Non-Iterative-Time-Advancement is chosen 
to speed up the calculation.  Surface and volume monitors are also set to monitor for 
velocity at pressure-outlet; and also blood clot volume fraction at the artery cell zone.  
Upon initialization; the clot region is adapted and patched.  The blood clot is patched 
with cylindrical shape of radius 1.35mm, and length 4mm.  The location of patched 
clot is 3mm from the periphery of ‘GP’ device.   
 
With varying inlet pressure set up for each simulation case and two models, this made 









Once the simulation cases are solved, post-processing to extract and analyse the data 
obtained are done.  Contours for blood clot volume of fraction are observed for 
selected flow times are displayed and animated.  A graph to represent the fraction of 
clot suction against time is also plotted to deduce the best design for blood clot 





The tools/software used to carry out this research is listed: 
 ANSYS DesignModeler™ 
 ANSYS FLUENT™ 14.0  
 
For detailed view of the Gantt Chart during the commencement of this project, kindly 






4.1 Grid Sensitivity Study  
 
The idea behind meshing and simulation is breaking down a physical domain into 
small discrete control volumes whereby calculations of the set of equations are done.  
The variables are iterated to every adjacent cell until a certain tolerance value is 
reached and the iteration/calculation is stopped and deemed to have converged.  The 
accuracy of the variables/parameters calculated is fully dependent upon the size of the 
discrete control volumes (cells).  Ideally, smaller cells results in more accurate 
calculation, but at the risk of higher computation time.  Hence, grid sensitivity study is 
carried out to compare the accuracy of the calculation for a range of grid sizes.  The 
best grid size shall be the largest grid which is adequately accurate. In each case, the 
grid density was varied from coarse to fine by increasing the number of cells in the 
whole device generally, including the wall.  Grid independency is said to be achieved 
when any further increase in the number of cells did not adversely affect the 
simulation results; the optimum grid size avoided any unnecessary prolonged 
computational effort required for the simulations with large number of cells 
(KuShaari, A.Rahman, & Pearce, 2012).   
 
To carry out the grid size study, a surface monitor at pressure outlet was selected, to 
monitor for the velocity at every flow time.  Then, a graph showing the velocity at 




Figure 14: Graph of velocity against flow time for each of the grid sizes 
 
The velocity against flow time pattern for 0.25mm and 0.2mm size is relatively 
similar, and since the largest of the chosen grids are chosen to cut computation time, 
0.25mm grid size should be chosen.  However, to obtain better clot shape upon 
patching, a finer grid size is preferred.  To fit this purpose, 0.2mm is chosen because it 
is relatively fine, with reasonable amount of computational cells to avoid unnecessary, 

















































4.2 Clot Behaviour Study  
 
In this section, the qualitative and quantitative behaviour of blood clot upon extraction 
by ‘GP’ 2 devices at different pressures are analysed and compared to determine 
which of the two proposed designs are better.   
 
4.2.1 Qualitative Visualization of Clot Behaviour at 40, 50 and 60kPa 
In this section, the clot behaviour upon extraction is visualised for both proposed 
designs at 3 different pressures.  The results are as tabulated below:  
40kPa 




























































































Table 6: Summary of clot behaviour visualization for both models at 40kPa 
 
From the visualization shown, an early conclusion could be drawn.  It is clear that 
qualitatively, ‘GP’2 Model 1 which has cylindrical tube design is much more efficient 
(faster) in extracting blood clot than the helical spiral design for all three pressures.  
Besides that, as pressure increases, the time for removal of blood clot decreases.  




4.2.2 Quantitative Analysis of Clot Behaviour at 40, 50 and 60 kPa 
A graph showing the volume fraction of blood clot in the artery region is plotted 
against time for both models at different pressures.   
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The table below summarizes the time taken for complete clot extraction for both 
model at three different pressures. 
Pressure / Model Extraction time for  
‘GP’ 2 Model 1 
Extraction time for  
‘GP’ 2 Model 2 
40 kPa 6.92µs 27.97µs 
50 kPa 5.75µs 17.28µs 
60 kPa 4.98µs 12.11µs 
Table 7: Summary of extraction time for complete blood clot removal  
 
From the data extraction carried out qualitatively and quantitatively, it can be proven 
that ‘GP’ 2 Model 1 is a better design as compared to ‘GP’ 2 Model 2; because it 
allows blood clot extraction at shorter time for all three pressures.  The cylindrical 
shaped tubes are more efficient in the suction process as compared to the helical spiral 
design because with cylindrical shapes, the air suction travels at shorter distance thus 
reaching the clot quicker, to allow extraction to occur.  With 9 cylindrical tubes, i.e. 9 
sources of suction, it facilitates in breaking up the clot into smaller fragments.  When 
the source for suction (i.e. number of tubes) is increased, cylindrical shapes are better 
in clot extraction because the cylindrical-shaped geometry works by the same-suction 
principle allowing more suction power.  This type of phenomena is normally found in 
nature; e.g. the stomata found in leaves.  The vortex creation process which is 
observed upon suction by the helical spiral design, compared to the same-suction 
principle process is less efficient (requires more time) in clot extraction at the same 
applied pressure.   
 
In the earlier studies for the invention of ‘GP’ device, a model of one cylinder and one 
helical spiral tube are compared.  In this study, the helical spiral model proves to be 
better at clot extraction because the helical spiral design a vortex flow in the artery 
between the clot and catheter, thus motivates the fragmentation (breaking up) of the 
clots to allow recanalization.  However, when the number of tubes (both cylindrical 
and helical spiral) is increased in amount, the result shows contradicting findings.  
This is because the same-suction principle works best when surface area of suction is 
increased.   
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In this research we found out that these 9 cylindrical tubes are able to break the clot, 
(fits the function of vortex creating design) at lower time because distance travelled is 
shorter for both air suction and clot extraction.  Hence, we conclude that ‘GP’2 Model 










As a conclusion, the simulation for the extraction of blood clot using ‘GP’ 2 Device is 
essential for the development for the cure of stroke.  Not only it can be used for 
patients of stroke, but any diseases associated with blood clot such as peripheral 
vascular disease can also benefit if this device is approved for clinical use.  The 
objectives of this project are in line with the ultimate goal for developing this device 
whereby it identifies other potential design the best determines its applicability in 
clinical use.   
For the case of selecting the grid size, it is clear that finer grids results in higher 
accuracy calculations i.e. better results.  However, this is achieved at the cost of 
prolonged computational time.  Therefore, from grid sensitivity study to identify the 
optimum grid size that is fine enough to generate accurate calculations but large 
enough to avoid extra computational time; the grid size of 0.2mm is used.   
 
The design for ‘GP’ 2 Model 1 device is better at clot extraction than the Model 2 
device because the distance travelled for air suction and clot extraction is shorter, in 
cylindrical tubes.  For both models, it can be shown that higher pressure extracts 
blood clot at lower time whereby the fastest clot extraction occurs at time 0.00498s 
for Model 1, and 0.01211s for Model 2 both occurring at 60 kPa.  
 
For future work continuation, experimental data shall be compared with the 
simulation outcomes for model validation.  This will further prove the findings 
obtained in this research work.  In terms of model development, it is suggested that 
smaller diameter tubes but higher in number could facilitate faster clot breaking 






Fluent 6.3 User Guide . (2006, September). ANSYS Inc. . 
Bernsdorf, J. (2005). Concurrent Numerical Simulation of Flow and Blood Clotting using the 
Lattice Boltzmann Technique. IEEE. 
Crosta, P. (2009, August 17). What is a Stroke? What causes a Stroke? Retrieved June 17, 
2012, from Medical News Today: 
http://www.medicalnewstoday.com/articles/7624.php 
Gobin, Starkman, Duckwiler, Grobelny, Kidwell, Jahan, et al. (2004). MERCI 1: A Phase 1 
Study of Mechanical Embolus Removal in Cerebral Ischemia . Stroke; Journal of the 
American Heart Association. 
Kiris, C., & Kwak, D. (2007). Space Technology and CFD Applied to the Development of the 
DeBakey Heart Assist Device. Revolutionary Technology NASA, pp. 76-78. 
KuShaari, K., A.Rahman, A., & Pearce, G. (2012). CFD Simulation of Blood Clot Behaviour 
using GP Device. UKSim 2012, 75-80. 
Nohirnyak, V., Suk, W., & Holland, C. (2006). Acousto-mechanical & Thermal Properties of 
Clotted Blood. National Institutes of Health, US. 
Pearce, G., & Perkinson, N. (2009). Biomechanical Probe. US Patent Application Publication. 
Pearce, G., Jaegle, F., Gwatkin, L., Wong, J., Perkinson, N., & Spence, J. (2009). An 
Investigation of Fluid Flow Through a Modified Design for the 'GP' Device. IEEE, 
191-195. 
Pearce, G., Patrick, J., & Jaegle, F. (2006). The Design, Implementation, and Testing of a 
New Revolutionary Device for the Removal of Blood Clots in the Arterial System. 
UKSim 2006, 6-9. 
Pearce, G., Patrick, J., & Perkinson, N. (2007). A New Device for the Treatment of 
Thromboembolic Strokes. Journal of Stroke and Cerebrovascular Diseases, 167-172. 
Pearce, G., Perkinson, N., & Patrick, J. (2008). Modelling of the 'GP' Mechanical 
Thrombectomy Device MTD. IEEE, 499-502. 
Pearce, G., Perkinson, N., Romero, G., Martinez, M., & Felez, J. (2011). Applicability of the 
GP Device to the Circle of Willis Arteries by Using a Mathematical Model. IEEE. 
 37 
 
Pearce, G., Perkinson, N., Wong, J., Burley, M., Spence, J., Brookfield, P., et al. (2009). The 
"GP" Mechanical Thrombectomy Device. Journal of Stroke and Cerebrovascular 
Diseases, 288-293. 
Pearce, G., Perkinson, N., Wong, J., Roffe, C., Brooker, L., Jones, K., et al. (2010). In Vitro 
Testing of a New Aspiration Thrombus Device. Journal of Stroke and 
Cerebrovascular Diseases, 121-129. 
Romero, G., Higuera, I., Martinez, M., Pearce, G., & Perkinson, N. (2010). Analysis and 
simulation of the adhesion forces between clot and the artery wall for a novel 
thrombectomy device applied to the Middle Cerebral Artery. IEEE, 195-200. 
Serza, I., Tratar, G., & Blinc, A. (2005). Blood Clot Dissolution Dynamics Simulation during 
Thrombolytic Therapy. Journal of Chemical Information Model, 1686-1690. 
Soleimani, S., Pennati, G., & Dubini, G. (2011). Numerical Simulation of Thrombus 
Aspiration Catheter: Preliminary Results. In International Conference on 
Advancements of Medicine and Health. (pp. 256-259). Romania. 
Tennuci, C., Pearce, G., Wong, J., Nayak, S., Jones, T., Lally, F., et al. (2011). Comparison of 
the Effectiveness of Three Methods of Recanalization in a Model of the Middle 
Cerebral Artery: Thrombus Aspiration via a 4F Catheter, Thrombus Aspiration via the 
GP Thrombectomy using the Solitaire Thrombectomy Device. Stroke Research and 
Treatment. 
Wedro, B. (2009). Stroke. Retrieved June 13, 2012, from MedicineNet.com: 
http://www.medicinenet.com/stroke/article.htm 
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4 Submit Draft Report
5 Submit Dissertation (soft bound)
6 Submit Technical Paper
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